Neuroendocrine tumors of the diffuse neuroendocrine system.
about
Carcinoid tumorsFrequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulationGene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasiaThe somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cellsA Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis.Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours.Identification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomes.Prevalence and clinicopathological characteristics of appendiceal carcinoids in Sharjah (United Arab Emirates)Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells.Detection and organ-specific ablation of neuroendocrine cells by synaptophysin locus-based BAC cassette in transgenic miceBone metastases and skeletal-related events from neuroendocrine tumors.Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible?Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET)Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoids.Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor.Small Bowel Carcinoids: A Single Surgeon's Experience in Southern IndiaHealthcare and economic impact of diarrhea in patients with carcinoid syndrome.Chromogranin A - unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfallsMetastatic type 1 gastric carcinoid: a real threat or just a myth?Small cell neuroendocrine carcinoma of the oropharynx harbouring oncogenic HPV-infection.Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology.Synthetic paclitaxel-octreotide conjugate reversing the resistance of A2780/Taxol to paclitaxel in xenografted tumor in nude mice.An Appendiceal Carcinoid Tumor within an Amyand's Hernia Mimicking an Incarcerated Inguinal HerniaEndoscopic resection for gastrointestinal neuroendocrine tumors.Lanreotide for the treatment of gastroenteropancreatic neuroendocrine tumors.Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II.Molecular features and clinical outcome of lung malignancies in very young people.Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors.Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines.Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines.Management of bronchial carcinoid: An anaesthetic challenge.Resection of liver metastasis from neuroendocrine tumors: evaluation of results and prognostic factors.Unusual presentation of a left testicular carcinoid.PAX8 is expressed in pancreatic well-differentiated neuroendocrine tumors and in extrapancreatic poorly differentiated neuroendocrine carcinomas in fine-needle aspiration biopsy specimens.Tumor size and depth predict rate of lymph node metastasis in colon carcinoids and can be used to select patients for endoscopic resection.Tumor size and depth predict rate of lymph node metastasis and utilization of lymph node sampling in surgically managed gastric carcinoids.Chemotherapy in NETs: When and how.Effects of Sandostatin LAR on gastrointestinal motility in patients with neuroendocrine tumors.Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?MicroRNA analysis of gastroenteropancreatic neuroendocrine tumors and metastases.
P2860
Q24614827-A1A98477-264E-494C-815C-40BA5DE2D5EAQ24655168-EA4796DA-EE8B-46AC-A6E1-32AD005179C2Q28476512-3C96D027-9473-4708-90E2-B2B327D18668Q28484664-8B29A08F-F514-4275-ACF8-403A5D5F4D68Q30277102-2B439D25-7E98-4A36-B681-CC70A52BD1ADQ33392694-55955516-A83E-4EA6-A624-8E7FB0F17CE2Q33812900-67484728-D4F6-49AD-921E-66B0BAE430EDQ33883381-DEB3116E-F9A0-4E8F-AA23-A7EB835015CFQ34178183-F01AB0D8-171D-4B93-BE2B-6DE64F527187Q34695421-56562C01-B0D1-4EA0-9D31-5BF0C6C9C612Q34850930-154E0EDE-60E0-40FB-8B58-905F268C76F4Q35771217-2ECDA19C-98A2-440A-8C2A-063F5B307335Q36065003-2A335B21-0BCF-44EF-AC6F-6BB773237AECQ36149338-D5590E2E-B458-4A92-B833-195A43C84FE3Q36335128-6670631A-2210-43A3-A82E-A1437B049CDBQ36343599-DFAC1CC9-5B1B-4FA0-B513-74ED8331D65BQ36501706-E1D3B3E9-A888-4ED6-8E18-8D95456AD667Q36582343-112F3EDC-A61B-4064-9F46-92C972E54AF0Q37408868-1BF84859-0240-484A-975D-88AD5FA86481Q37631286-6662EEF6-94CC-44EF-8DB8-2F6D018FC66DQ37634917-EBD92901-C3C5-49B9-8A65-07644CD6960CQ37696327-AA09966A-91BC-48C9-B6D4-D873EBC93F24Q37737712-A8C0A671-AC77-4485-B770-F2769D674D38Q38132280-0F6B1137-1F9F-4603-9FA0-96C46E7263B0Q38658730-7DD5FD30-52C5-48EF-A9F8-73DD96781A42Q38849324-A0362987-529B-4651-8592-F6FFD6B1B0CDQ39022545-3FF024B0-5A03-4CF2-A65F-8777A6A8C075Q39773838-FEDBC09C-BFFA-4D9D-9D1C-A0A86E909D77Q39820388-4FFC8A79-4C96-4137-A4AB-E5523119241CQ39962632-1F9B6721-2827-4C12-9DBE-E8C4663D0703Q40493571-9FEE4C7D-E5AE-41D9-A825-D9ADFB687EF5Q40920023-7CA8863D-7E4D-4D8D-95A7-7B103E0C15E4Q42107983-FDE72609-F57F-43EC-8408-E8D7A8A2628FQ46817833-439BF1DB-5AF6-4D19-BF35-DA0C917B61E2Q47340025-EDD0488F-FD72-4636-9297-34A427520132Q47383380-869548CC-B53A-4D52-9225-8184C5675D1DQ47692261-6A462A44-B2E2-483B-88CF-C6FAF936D8EFQ50679640-925AC89E-8702-4904-A64C-425446B8D0C9Q52744623-CDD0E0BA-08AB-4766-B0BB-AB0A766B0972Q55452160-E425CD50-1340-477E-A646-4811B51F865F
P2860
Neuroendocrine tumors of the diffuse neuroendocrine system.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuroendocrine tumors of the diffuse neuroendocrine system.
@en
Neuroendocrine tumors of the diffuse neuroendocrine system.
@nl
type
label
Neuroendocrine tumors of the diffuse neuroendocrine system.
@en
Neuroendocrine tumors of the diffuse neuroendocrine system.
@nl
prefLabel
Neuroendocrine tumors of the diffuse neuroendocrine system.
@en
Neuroendocrine tumors of the diffuse neuroendocrine system.
@nl
P2093
P1476
Neuroendocrine tumors of the diffuse neuroendocrine system.
@en
P2093
Björn I Gustafsson
Irvin M Modlin
P356
10.1097/CCO.0B013E3282F1C595
P577
2008-01-01T00:00:00Z